albuterol has been researched along with Cachexia in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbó, N | 1 |
| López-Soriano, J | 1 |
| Tarragó, T | 1 |
| González, O | 1 |
| Llovera, M | 1 |
| López-Soriano, FJ | 1 |
| Argilés, JM | 1 |
1 other study available for albuterol and Cachexia
| Article | Year |
|---|---|
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Body Weight; Cachexia; Clenbuterol; Ea | 1997 |